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ABSTRACT
EndA is a membrane-attached surface-
exposed DNA-entry nuclease previously known to
be required for genetic transformation of
Streptococcus pneumoniae. More recent studies
have shown that the enzyme also plays an important
role during the establishment of invasive infections
by degrading extracellular chromatin in the form
of neutrophil extracellular traps (NETs), enabling
streptococci to overcome the innate immune
system in mammals. As a virulence factor, EndA
has become an interesting target for future drug
design. Here we present the first mutational and bio-
chemical analysis of recombinant forms of EndA
produced either in a cell-free expression system or
in Escherichia coli. We identify His160 and Asn191 to
be essential for catalysis and Asn182 to be required
for stability of EndA. The role of His160 as the
putative general base in the catalytic mechanism is
supportedbychemicalrescueoftheH160Avariantof
EndA with imidazole added in excess. Our study
paves the way for the identification and development
of protein or low-molecular-weight inhibitors for
EndA in future high-throughput screening assays.
INTRODUCTION
The surface-exposed DNA-entry nuclease EndA from
Streptococcus pneumoniae is a membrane-bound enzyme
required for DNA uptake during genetic transformation.
The enzyme is responsible for processing double-stranded
DNA into single-stranded fragments that in turn enter the
microbial cell (1). Mutations within the endA gene
effectively block DNA-uptake by S. pneumoniae due to
the reduced nuclease activity (2). More recently, another
important function of surface-exposed streptococcal
EndA as a bacterial virulence factor was discovered.
During infections, the enzyme is able to cleave the DNA
scaffold of neutrophil extracellular traps (NETs) (3,4).
NETs are anti-microbial chromatin barriers expelled
by activated neutrophils and other cells of the innate
immune system (5,6). By doing so, EndA enables
streptococci to escape the innate immune response
in mammals and supports spreading of the pathogenic
organism, increasing the risk of a life-threatening
invasive infection. Thus, EndA appears to be a potential
target for the identiﬁcation and/or design of speciﬁc
nuclease inhibitors that could be turned into effective
drugs ﬁghting streptococcal infections.
A primary sequence analysis shows that some DNA-
entry or competence-associated nucleases contain a
conserved DRGH-motif and, additionally, exhibit the
well-known H-N-H-motif indicating a structurally
conserved active site (7). The H-N-H-motif is found in
many other sequence-speciﬁc and nonspeciﬁc nucleases
as well as in His–Cys box enzymes which can all be
grouped together into the large bba-Me ﬁnger nuclease
superfamily (8). Within this family, the DRGH-motif
containing nucleases obviously form two subgroups. The
ﬁrst subgroup consists of so-called sugar nonspeciﬁc
enzymes (such as Anabaena nuclease, Serratia nuclease
or mitochondrial Endonuclease G) found in all branches
of life. As revealed by a BLAST-search for homologous
proteins with Anabaena nuclease as a query, this ﬁrst
group currently comprises 1291 hits in 451 species
including archaea, bacteria, fungi, metazoa and plants
(9–11). In contrast to the ﬁrst group, homologs of EndA
were found with 629 hits in 207 species, but only in
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for the so-called dyad symmetry-binding protein
(gi: 33339902).
In the present study, we report the molecular cloning
and expression of recombinant EndA and demonstrate by
site-directed mutagenesis and biochemical analyses that
EndA is indeed a member of the DRGH-motif-containing
nuclease family. Due to an apparent extreme toxicity of
EndA we were not able to clone and express wild-type
endA gene in Escherichia coli. However, the inactive
variant EndA H160A could be cloned, expressed and
puriﬁed successfully. Expression of wild-type EndA and
several active-site mutants was achieved by using a
cell-free expression system employing gene splicing
generated by overlap extension PCR using the EndA
H160A encoding plasmid DNA as template (12). The
activity of EndA H160A expressed in E. coli could be
restored in vitro by chemical rescue with excess imidazole
that apparently replaces the histidine side chain absent in
this variant. Our results provide a solid basis for future
structural and functional studies of this important class
of DNA-entry nucleases.
MATERIALS AND METHODS
Expression of pelB EndA H160A
The endA H160A gene was cloned in vector pET25b+
(Novagen). EndA H160A protein, fused at its
N-terminal end to a pelB leader sequence for periplasmic
localization, was expressed in E. coli BL21Gold(DE3)
(Novagen). Bacteria were separated by centrifugation
from the culture medium (LB broth). Proteins from cell
lysates before and after induction, LB-broth before and
after induction and from cell lysate after sonication as well
as the soluble fraction after sonication and centrifugation
were separated on a 12.5% SDS–PAGE gel.
Expression and puriﬁcation of EndA H160A
His-GST double-tagged EndA H160A fused via a TEV
protease cleavage site [EMBL Protein Expression and
Puriﬁcation Facility (pETM30)] was expressed in E. coli
BL21 Star (DE3) cells (Invitrogen). Cells were grown in
LB-broth containing kanamycin. Expression was induced
at an OD
600 of 0.5 by supplementing the medium with
1mM isopropyl b-D-1-thiogalactopyranoside (IPTG)
(ﬁnal concentration), and cells were harvested after a
further 4h. Soluble EndA H160A was puriﬁed according
to the user manual for Protino Ni-IDA 2000-packed
columns with slight modiﬁcations. Columns were washed
with 50mM NaH2PO4/NaOH pH 8.0, 750mM NaCl
(containing high salt for nucleic acid removal). Eluted
fractions were dialyzed directly against a TEV-protease
reaction buffer (50mM Tris–HCl pH8.0, 1mM DTT,
0.5mM EDTA). His-GST was clipped off using
His-tagged TEV-protease (MobiTec) with a concentration
of 25U/mg His-GST-EndA H160A overnight at 4 C.
After dialyzing against 50mM NaH2PO4/NaOH pH8.0,
300mM NaCl and 20mM imidazole, the protein mixture
was incubated with Ni
2+-NTA agarose (Qiagen).
Untagged EndA H160A was recovered from the ﬂow
through. In a ﬁnal puriﬁcation step the ﬂow through
was applied to a Superdex-75 HR10/30 column using
50mM NaH2PO4 pH 8.0, 300mM NaCl, 0.01% Triton
as eluant. Bovine serum albumin, ovalbumin,
a-chymotrypsin, and cytochrome c were used as protein
standards to determine the apparent molecular mass of
EndA H160A. Fractions containing EndA H160A were
collected and concentrated using CENTRIPLUS
(Centrifugal Filter Devices, MW cut-off: 10000;
MILLIPORE).
For small-angle X-ray scattering (SAXS) experiments,
the Rosetta2 (DE3) expression strain (Novagen) was
transformed with pET30M-EndA H160A. The cells were
grown at 37 C in LB with 100mg/ml kanamycin, 25ug/ml
chloramphenicol until A
600 reached a value of 0.8–1.0.
The temperature was then decreased to 18 C, and
protein expression was induced by the addition of
0.4mM IPTG. Protein expression continued overnight at
18 C. The cells were pelleted by centrifugation and lysed
by sonication in 25mM Tris–HCl pH 7.5, 1M NaCl, in
the presence of Complete Protease EDTA-free Inhibitors
(Roche). The soluble fraction was bound in-batch to
glutathione 4B resin (GE Healthcare) for 1h at 4 C.
Unbound protein was removed by repeated washes
with 25mM Tris–HCl pH 7.5, 1M NaCl. EndA H160A
was cleaved from the resin by overnight digestion
with TEV protease at 4 C. The cleaved protein was
concentrated to 50mg/ml using Centricon Plus-70 concen-
trators (Millipore), then loaded onto a Superdex 200 16/60
column (GE Healthcare) equilibrated in 25mM Tris–HCl
pH 7.5, 75mM NaCl. Peak fractions containing EndA
H160A were pooled and concentrated to  50mg/ml
using an Amicon Ultra-15 concentrator (Millipore).
SAXS data acquisition and processing
SAXS data were collected at 25 C on the X9 beam line
at the National Synchrotron Light Source (Brookhaven
National Laboratory) or the 18ID beamline at the
Advanced Photon Source (Argonne National
Laboratory). The wavelength of the beam was 0.855 or
1.033A ˚ and the sample to detector distance was 2.0 or
2.36m, respectively. SAXS data were collected on four
concentrations of EndA H160A, ranging from 1 to
5mg/ml in 25mM Tris–HCl pH 7.5, 75mM NaCl.
Scattering data were circularly averaged and scaled to
obtain a relative scattering intensity as a function of
momentum transfer vector, q [(4psiny)/l], after subtrac-
tion of buffer-scattering contributions.
SAXS data analysis and model construction
All scattering data were analyzed using the Primus
software package; the GNOM45 software package was
used for all P(r) and I0 analyses (13,14). The radius of
gyration, Rg, and forward scattering, I0, were calculated
from the second moment and the start of P(r), respect-
ively, where Rg is the root mean square of all elemental
volumes from the center-of-mass of the particle, weighted
by their scattering densities, and I0 is directly proportional
to the molar particle concentration, multiplied by the
square of the scattering-particle molecular weight for
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Horse-heart cytochrome c was used as a standard refer-
ence protein for all I0 analysis. Guinier plots for EndA
were linear over a q-range of 0.012–0.079A ˚ (Figure 2A).
The three-dimensional shape of EndA was constructed
from the SAXS data using the GASBOR22IQW program
(q-range input for each analysis was from 0.01 to
0.04A ˚  1), by calculating the distribution of linearly con-
nected 1.9A ˚ spheres that best ﬁt the scattering data (15).
The calculation was repeated ﬁve times with different
random starting points for the Monte Carlo optimization
algorithm; no predeﬁned shape or symmetry constraints
were used. From these runs, the predicted structure with
the lowest deviation of the calculated scattering proﬁle
from experimental data was used for interpretation
(Figure 2B). To compare the SAXS-based models with
the atomic structures, the SUPCOMB13 and CRYSOL
programs were used (16,17).
Chemical rescue of the nuclease activity of EndA H160A
EndA H160A (20nM) was incubated with a plasmid
substrate (15ng/ml, pBluescript SK(+), Stratagene) and a
triple buffer containing 10mM sodium acetate, 10mM
MES, 20mM Tris–HCl, pH 8.0, 5mM MgCl2 and
200mM imidazole. After 2, 5, 10 and 20min, aliquots
were taken and the cleavage reaction stopped using a
loading dye containing 250mM EDTA. As a control,
substrate plasmid was incubated for 20min in the
absence of EndA H160A. The reaction products were
analyzed by agarose gel electrophoresis (0.8%). The
same experiment was done at different pH values (pH
5.5, 6.5, 7.5, 8.5 and 9.5) in triple buffer whose pH was
adjusted with HCl or NaOH, respectively. EndA H160A
was diluted in the triple buffer at the pH used for the
activity measurement. Each experiment was repeated
three times. The ratio of open-circular to super-coiled
DNA was calculated from the intensity of the bands
using the TINA2.0 software package.
Sequence alignment
Sequences of the aligned DRGH-motif-containing nucle-
ases were retrieved using the basic local alignment search
tool BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) via
the National Center for Biotechnology Information
(NCBI) web server with the amino acid sequences of
Anabaena nuclease (gi: 39041) or EndA (gi: 47374) as
the query. Alignment of the primary structure of
selected proteins was performed using ClustalW2 (http://
www.ebi.ac.uk/Tools/clustalw2/index.html) via the web
server of the European Bioinformatics Institute (EBI).
According to the results obtained from our mutational
and biochemical analyses the alignments were manually
corrected using GeneDoc (http://www.nrbsc.org/gfx/
genedoc/) or BioEdit (http://www.mbio.ncsu.edu/
BioEdit/bioedit.html) software packages to match all
amino acid residues with identical functions.
In vitro synthesis of EndA
DNA encoding EndA H160A cloned in plasmid pET25b+
(Novagen) was used as a template for overlap extension
PCR based on the procedure described by Heckman and
Pease to generate wild-type endA PCR product
12. Using
this as a template for further overlap extension PCR, all
other variants of EndA (D157A, R158A, H160A, N179A,
N182A and N191A) were generated. All constructs
contain a T7 promoter sequence followed by a ribosomal
binding site as described in the instruction manual for
the PURExpress
TM In vitro Protein Synthesis Kit (New
England BioLabs). Protein synthesis was set up as a
25ml reaction with 250-ng template DNA for each
construct; incubation was for 2h at 37 C.
In-gel activity assay
Aliquots of the unpuriﬁed protein-synthesis reaction
mixture (3ml) were analyzed on a 15% SDS–PAGE gel
containing 30mg/ml high-molecular-weight herring sperm
DNA. After washing with water to remove SDS, the gel
was incubated at ambient temperature in 40mM Tris–
HCl, pH 7.7, 2mM MgCl2 to renature the nuclease. The
gel was subsequently stained with ethidium bromide to
detect in-gel DNA cleavage.
Single radiation enzyme diffusion assay
Petri dishes were prepared with 20ml of 1% agarose
solution in 40mM Tris–HCl, pH 7.7, 2mM MgCl2 con-
taining 30mg/ml high-molecular-weight herring sperm
DNA. The agarose gel was pre-stained with ethidium
bromide. Crude protein-synthesis reaction mixture (1ml)
and as control 1ml DNaseI (Fermentas, 1U/ml) with 1ml
of 40mM Tris–HCl, pH 7.7, 2mM MgCl2 were applied to
wells with a diameter of 2mm. Plates were incubated over-
night at ambient temperature. The diameter (mm) of the
halos was measured (18). For calibration, 0.062, 0.25, 1,
1.5 and 4ml of the wild-type EndA protein synthesis
reaction mixture were used. In the calibration curve, the
diameter of the halos was plotted against the amounts of
the wild-type EndA protein-synthesis reaction mixture.
This curve was used to calculate the relative activity of
the variants, whose concentration in the respective crude
protein synthesis reaction mixture was estimated by a
western blot analysis.
Western blot analysis
For analysis of the in vitro synthesis reaction, all EndA
variants (crude protein-synthesis reaction) were separated
on a 12.5% SDS–PAGE gel and electrophoretically
transferred onto a PVDF transfer membrane
(Amersham Hybond
TM
-P). Proteins were probed with a
monoclonal mouse anti-FLAG M2-peroxidase conjugated
antibody (SIGMA, dilution 1:500) and visualized using
the Amersham
TM ECL Plus Western Blotting Detection
System. Quantitative western blot analysis was carried out
using the TINA2.0 software package.
To analyze the various steps of the puriﬁcation of EndA
H160A, protein samples were separated on a 15% SDS–
PAGE gel and electrophoretically transferred onto a
PVDF transfer membrane (Amersham Hybond
TM -P).
Proteins were probed with a non-conjugated anti-GST-
antibody (Pharmacia Biotech, dilution 1:2.000) and
detected with anti-Sheep/Goat IgG-POD Fab-fragments
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bands were visualized as described above.
Cleavage preferences of EndA
The wild-type EndA protein-synthesis reaction mixture
was diluted 1:100 for cleavage of X174 DNA (New
England Biolabs): 8.4nM single-stranded circular DNA
4.2nM double-stranded, circular DNA and 4.2nM
double-stranded nicked DNA in 40mM Tris–HCl, pH
7.7, 2mM MgCl2 at ambient temperature. At the
indicated time points, aliquots (10ml) of each reaction
mixture (100ml) were analyzed on 0.8% agarose gels; the
DNA was visualized by ethidium bromide staining.
RESULTS
Molecular cloning and expression of EndA in E. coli
All efforts to clone and express EndA in E. coli using
tightly repressed expression systems with or without secre-
tion of the recombinant protein into the periplasmic space
remained unsuccessful. In all cases, subsequent sequencing
of recovered recombinant plasmids revealed mutations in
the regions encoding the proposed active site and/or inser-
tion of stop codons preventing the expression of
full-length wild-type EndA protein (data not shown). We
therefore generated the putatively inactive H160A variant
with an exchange of the histidine residue from the DRGH-
motif of EndA for alanine and veriﬁed its expression as a
secreted protein due to fusion to the pelB leader sequence
via cloning into pET-25(+) (Novagen) for periplasmic lo-
calization (Figure 1A). Soluble processed and secreted
EndA H160A could be detected and recovered by Ni
2+-
NTA afﬁnity chromatography from the culture medium as
well as from the cell lysate of E. coli after induction of
transformed cells. From SDS–PAGE analyses of this
system it was obvious that the amount of unprocessed
intracellular protein still containing the pelB leader
sequence was relatively high even after induction with
low amounts of IPTG (0.1mM ﬁnal concentration) and
fermentation at reduced temperatures (22 C), explaining
why the wild-type enzyme could not be expressed.
Surprisingly, EndA H160A protein fused to pelB turned
out to be highly soluble upon expression in E. coli in
contrast to other nonspeciﬁc nucleases of the
DRGH-motif containing type such as Anabaena nuclease
or Serratia nuclease (Figure 1A) (19,20).
As intracellular EndA H160A was soluble and
non-toxic to E. coli, we generated and expressed a His-
GST double-tagged version of EndA H160A in E. coli
using the pET30M expression vector (Figure 1B, upper
panel). The recombinant fusion protein with a theoretical
molecular mass of 55.6kDa could be expressed and
puriﬁed over a Ni
2+-IDA-afﬁnity chromatography
column. After afﬁnity puriﬁcation, the double tag was
clipped off by TEV-protease cleavage resulting in a non-
tagged EndA H160A variant. His-tagged GST and TEV-
protease were separated from EndA H160A using
Ni
2+-NTA-Agarose. The untagged nuclease could be
recovered from the supernatant (Figure 1B, upper
panel). A western blot analysis using anti-GST antibody
was performed in order to verify nuclease recovery
(Figure 1B, lower panel). In a ﬁnal puriﬁcation step,
residual contaminations were removed from untagged
EndA H160A by size-exclusion chromatography over a
Superdex-75 HR10/30 column (Figure 1C). This analysis
also revealed that EndA eluted as a monomeric protein
with an apparent molecular mass of 25.5±4kDa
(Mtheo=26.8kDa) as derived from three independent
gel ﬁltration runs (Figure 1D).
Analysis of EndA by SAXS
In order to determine its approximate size and shape,
EndA was analyzed with SAXS (Figure 2A). Guinier
plots were found to be linear over a q-range of
0.012–0.079A ˚ , consistent with the conclusion that the
samples are monodisperse. Guinier analysis of the low-q
regions yielded Rg values of 19.1±0.3A ˚ averaged over
four concentrations with a Dmax value of 55A ˚ ; no signiﬁ-
cant variation of Rg was observed upon dilution. The
calculated R value is similar to the value of 18.6A ˚
calculated from the crystal structure of the monomeric
Anabaena nuclease A (pdb ﬁle: 1zm8) (21). Additionally,
a I
2 value of 1.9 is obtained by ﬁtting the raw SAXS data
to the NucA crystal structure using CRYSOL, suggesting
that the two structures are similar in their global fold
(16,21). Io analysis, based on the scattering of a
standard protein (horse-heart cytochrome c), indicates
that the molecular mass of EndA is 29.0kDa, consistent
with expectations for a monomer (Figure 2A). An ab initio
shape was constructed from the I(q) scattering data using
the program GASBOR22IQW (Figure 2B) (15). The re-
sulting model has a globular shape with dimensions
similar to those of NucA, further supporting the similarity
of the shape and solution stoichiometry of the two
proteins (21).
Chemical rescue of EndA H160A activity
For EndA H160A, as expected, no nucleolytic activity
was detectable in any activity assay we applied.
However, since this variant was the only variant produ-
cible in E. coli, we tried to restore its activity by supple-
menting the reaction buffer with excess imidazole, which
in principle could complement the deleted side chain that
had been removed by substitution of the histidine residue
by alanine (Figure 3) (22,23). Using a plasmid-activity
assay the ratio of open circular to supercoiled DNA was
calculated based on the intensity of the DNA bands
obtained at selected time points at different pH values.
Intriguingly, EndA H160A showed nucleolytic activity
at pH values ranging from pH7.5 to 8.5 at a concentration
of 200mM imidazole as detected by an increase with
time of open, circular plasmid DNA (Figure 3B),
demonstrating restoration of enzyme activity by supple-
menting the chemical group required for the initiation of
catalysis. As a control, the plasmid DNA was incubated
with 200mM imidazole without enzyme for 20min at the
same pH values as used for the rescue experiments without
any detectable effect on the plasmid DNA.
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cell-free transcription/translation system
As it turned out to be impossible to express recombinant
wild-type EndA protein in E. coli, we used a cell-free
coupled transcription/translation system to produce
wild-type EndA and several EndA variants. Wild-type
EndA template DNA for cell-free expression was
generated by overlap-extension PCR using the EndA
H160A encoding plasmid to amplify two overlapping
gene segments in which the codon for Ala160 was
reverted to one coding for histidine (Figure 4A) (12).
Codon replacement was mediated by two internal
primers b and c containing the nucleotide substitution
within the overlapping region of the segmented gene.
The ﬂanking primer a included a ribosomal binding site
for extending the gene with a T7 promoter sequence by
amplifying the hybridization products with the universal
primer a’ also containing the RBS as complementary
sequence for the second PCR. The resulting protein was
FLAG-tagged at its C-terminus, due to ﬂanking primer d
containing the corresponding nucleotide sequence as an
add-on. The ampliﬁed wild-type endA sequence was used
in turn as a template for overlap-extension PCR to
generate the templates for variants D157A, R158A,
H160A, N179A, N182A and N191A. Variant H160A
was ampliﬁed using primers a and d and in a second
PCR extended with a T7-promoter sequence using
primers a0 and d.
Guided by the sequence alignment of DRGH-motif
containing proteins presented in Figure 4C we selected
certain amino-acid residues for our mutational analysis
of the presumptive active site of streptococcal EndA.
Asp157, Arg158 and His160 from the conserved
DRGH-motif, all localized in one of the two b-strands
of the bba-Me ﬁnger structure, were exchanged for
alanine (7,24,25). His160 within the DRGH-motif corres-
ponds to the ﬁrst histidine residue in the H-N-H-motif and
plays an essential role in catalysis acting as the general
Figure 1. (A) SDS–PAGE analysis of the expression of EndA H160A fused to the pelB leader sequence for periplasmic localization in E. coli.
(u) cells before induction, suspended in loading buffer (i) cells after induction, suspended in loading buffer; (med-u) concentrated culture medium
before induction, (med-i) concentrated culture medium after induction, (wcl-i) whole cell lysate after cell disruption by sonication and (sf-i) soluble
fraction after centrifugation of the whole cell lysate. (B) Puriﬁcation of His-GST double-tagged EndA H160A. Upper panel: SDS–PAGE analysis of
the lysate of transformed BL21-Gold(DE3) cells before (u) and after (i) induction; (IMAC-IDA) His-GST-EndA H160A puriﬁed via immobilized
metal ion afﬁnity chromatography using a Ni
2+-IDA-column; (TEV) cleavage of His-GST-EndA H160A with TEV protease; (IMAC-NTA ft) ﬂow
through after incubation with Ni
2+-NTA-Agarose; (SEC) EndA-H160A after size-exclusion chromatography. Lower panel: western blot using
anti-GST antibody to monitor the puriﬁcation steps described above. (C) Puriﬁcation of EndA H160A by size-exclusion chromatography: after
clipping off the His-GST double tag and incubation with Ni-NTA-Agarose the collected ﬂow through containing only untagged EndA H160A was
applied to a Superdex 75 column and eluted at a ﬂow rate of 1ml/min. The black triangle indicates the time point of sample loading. Elution of
proteins was monitored at 280nm. Peak I represents EndA separated from a residual contaminant (II). (D) Retention coefﬁcients (Superdex
75 column) of EndA and protein standards were determined and plotted against the natural logarithm of the molecular mass. The molecular
weight of 25.5±4kDa obtained for EndA, based on the ﬁtted curve, corresponds reasonably well with the calculated molecular weight of 26.8kDa
indicating that EndA is a monomer under these conditions.
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gine residues (Asn179 and Asn182) for alanine. As
candidates for the central asparagine residue in the H-N-
H-motif, these residues might be involved in
hydrogen-bond network formation and stabilization of
the bba-Me ﬁnger structure (28,29). According to our
sequence alignment, another asparagine residue, Asn191,
might assume the function of the metal ion ligand corres-
ponding to the histidine residue at the last position of the
H-N-H motif. In fact, DRGH-motif nucleases generally
contain an H-N-N motif (7,24,25).
Even though we were able to detect, by Coomassie
staining, protein synthesized with the control template
supplied with our cell-free transcription/translation
system, wild-type EndA and EndA variants could not be
detected by Coomassie staining after separation on SDS–
PAGE gels. However, a strong nuclease activity could be
detected for all variants, except for EndA H160A and the
control template supplied with the in vitro expression
cocktail, using an in-gel activity assay after separation of
synthesized proteins on SDS–PAGE gels containing
high-molecular-weight herring sperm DNA, after refold-
ing and ethidium bromide staining (Figure 4B, upper
panel). It should be noted here, that the activity seen in
the in-gel assay might not reﬂect the maximum activity of
a given EndA variant, since all proteins were refolded in
the same buffer but refolding efﬁciencies for the variants
might vary for the wild-type and mutant proteins. All
EndA variants could be detected by Western blot
analysis employing an anti-FLAG antibody (Figure 4B,
middle/lower panel). Intriguingly, the amounts of
protein produced in the cell-free expression system appar-
ently were inversely correlated to the activity of a given
variant (for activity, see Figure 5). The variants were
Figure 2. SAXS of EndA. (A) SAXS intensity I(q) data for EndA H160A (3.0mg/ml); the insets show the P(r) pair-wise vector length distribution
curve and Guinier ﬁt of the I(q) scattering data. The gray line in the I(q) scattering plot is the calculated scattering curve of NucA generated with
CRYSOL. (B) Ab-initio models derived from SAXS intensity data (surface representation) superimposed with a ribbon representation of the
Anabaena NucA crystal structure (pdb-code 1zm8).
Figure 3. Chemical rescue of the nuclease activity of the catalytically inactive EndA His160A variant by imidazole. (A) Aliquots of the reaction
mixture containing 20nM EndA H160A and 15ng/ml pBSK plasmid in triple buffer at pH 8.0 were taken at the time points indicated and the
reaction products analyzed by 0.8% agarose gel electrophoresis. The analysis shows an increase of open circular (oc) and a decrease of supercoiled
(sc) plasmid DNA over time. Plasmid DNA incubated for 20min in the absence of EndA H160A and plasmid (C) were loaded as controls. (B) The
experiment was repeated at different pH-values (pH 5.5–9.5) and the ratio of open circular to super-coiled plasmid DNA plotted against time (n=3).
EndA H160A showed nucleolytic activity at slightly basic pH values ranging from pH7.5 to 8.5.
628 Nucleic Acids Research, 2011,Vol. 39,No. 2Figure 4. (A) Generation of template DNA for in vitro protein synthesis via overlap extension PCR. Plasmid pET25+harboring the gene coding for
the inactive EndA H160A variant was used as a template for overlap extension PCR to generate the gene for wild-type EndA. The endA H160A gene
was segmented via ampliﬁcation in two separate PCR reactions with primer a containing a ribosomal binding site and primer b for segment AB, and
primers c and d containing the sequence coding for the FLAG tag in segment CD. The full-length gene was generated by using primer a0 containing a
T7 promoter sequence and primer d. Replacement of Ala160 by histidine was achieved by the two internal primer b and c introducing the nucleotide
substitution (black triangle) within the overlap of the gene segments. The PCR product was the template for in vitro synthesis of wild-type EndA and
for overlap extension PCR to produce the EndA variants D157A, R158A, N179A, N182A and N191A using primer c and d to introduce the
mutations. The gene for the variant H160A was generated with primer a and d and in a second PCR extended with the T7 promoter sequence with
primer a0, using d as reverse primer. (B) In-gel activity assay and western blot analysis of wild-type EndA and its variants. Upper panel: nuclease
activity of the crude in vitro protein synthesis reaction mixture of wild-type EndA and variants D157A, R158A, H160A, N179A, N182A and N191A
separated on an SDS–PAGE gel containing high-molecular-weight herring sperm DNA (ethidium bromide stained). The reaction mixture with the
control template supplied with the In vitro Protein Synthesis Kit (New England BioLabs) was used as a negative control (C). Dark bands correspond
to gel areas with digested DNA that are not stained with ethidium bromide. Middle and lower panel: western blot analysis of FLAG-tagged EndA
and variants D157A, R158A, H160A, N179A, N182A, N191A using an anti-FLAG antibody. Numbers indicate the amounts (ml) of the respective
crude synthesis reaction mixture loaded onto the gel. (C) Alignment of DNA-entry nucleases with other bba-Me-ﬁnger enzymes (H-N-H/N- and
DRGH-motif containing nucleases) of known structure. Indicated are amino acid residues selected for a substitution by alanine in S. pneumoniae
EndA. Mutations at positions 157, 158 and 160 concern the conserved DRGH-motif. Histidine at position 160 also represents the ﬁrst amino acid
within the H-N-H/N-motif and plays a central role in catalysis. One of two asparagines at positions 179 and 182 could represent the ﬁrst asparagine
residue of the H-N-H/N-motif, with asparagine 191 being the second. The alignment was manually reﬁned based on the structures of the listed
enzymes and our mutational analysis (Colicin E9, pdb code 1emv; Caspase-activated DNase (CAD), pdb-code 1v0d; T4 endonuclease VII, pdb code
1e7d; I-PpoI, pdb-code 1a74; Anabaena nuclease (NucA), pdb code 1zm8; Endonuclease G (dEndoG) from D. melanogaster, pdb code 3ism; Serratia
nuclease, pdb code 1smn). Secondary structure elements forming the core of the bba-Me-ﬁnger active-site motif are indicated by arrows (b-sheets)
and tubes (a-helices) as derived from the respective crystal structures. For the DNA-entry nucleases from S. pyogenes and S. pneumoniae (EndA) the
gi numbers are indicated.
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centration used for the protein synthesis reaction was
equal in all reactions. It is very likely that the synthesized
nucleases in the coupled transcription/translation system
are able to degrade the template DNA according to their
speciﬁc activity. Thus, the amount of protein produced for
a given variant increases in a feedback loop with the loss
of activity of a given nuclease variant caused by the amino
acid exchange. This is most obvious when comparing
wild-type EndA with the inactive variant H160A, which
was produced to the highest protein concentration
measured via Western blot analysis (Figure 4B, middle
and lower panel). Interestingly, the variant
EndA-N182A is an exception to this rule. Although it
only shows a moderate cleavage activity, this variant
apparently was instable producing only a weak signal in
the western blot when analyzed immediately after the syn-
thesis reaction and a decreased signal when analyzed after
a storage time of 2weeks (data not shown).
Determination of the activity of wild-type EndA and EndA
variants
The nucleolytic activity of the crude protein-synthesis
reaction mixture was quantiﬁed by measuring the size of
the halo by a single-radiation enzyme diffusion (SRED)
assay (Figure 5). For each enzyme variant, 1ml of the
synthesis reaction mixture was spotted onto an agar
plate containing high-molecular-weight DNA. Whereas
all EndA variants showed nuclease activity, the control
template supplied for the in vitro expression cocktail
showed none (Figure 5A). A quantity of 1U of bovine
pancreatic DNaseI was used as a positive control. The
relative concentration of each variant was determined by
western blotting (Figure 4B, lower panel). To calibrate the
system, different amounts of the wild-type EndA synthesis
reaction mixture were used in a separate SRED assay and
the size of the halos measured to obtain a calibration
curve (Figure 5B). Since the concentrations of the
variants relative to that of wild-type EndA was known
from the western blot analysis, the relative activities of
the variants could be determined (Figure 5C).
In a second type of activity assay, wild-type EndA was
tested on single-stranded, double-stranded, supercoiled
and nicked-phage DNAs, respectively, with a dilution of
1:100 of the crude protein-synthesis reaction mixture
(Figure 6). No pronounced difference of wild-type EndA
could be detected for the cleavage of single- or
double-stranded DNA as all substrates were digested
almost to the same extent, yet with a slight preference of
the enzyme for single-stranded DNA. The protein synthe-
sis mixtures obtained using either the template control
supplied by the in vitro expression kit or the EndA
H160A template, encoding the putatively inactivated
Figure 5. SRED assay: (A) Relative nuclease activity of the in vitro protein synthesis reaction mixture containing wild-type EndA, D157A, R158A,
N179A, N182A and N191A tested with high-molecular-weight herring sperm DNA embedded in 1% agarose (prestained with ethidium bromide),
40mM Tris–HCl, pH 7.7, 2mM MgCl2. Variant H160A showed no measurable activity in this assay. The reaction mixture with the control template
supplied with the in vitro Protein Synthesis Kit (New England BioLabs) was used as a negative control (C), DNaseI (Fermentas) as positive control.
The ruler indicates the diameter of the halos. (B) Calibration curve for the estimation of relative nucleolytic activity from the size of the halos. The
size of the halos (diameter in millimeters) was plotted against the amount (ml) of the protein synthesis reaction mixture containing wild-type EndA.
(C) The relative nucleolytic activity of each EndA variant contained in the crude reaction mixture was determined from the diameter of the halos
using the calibration curve in (B) and the concentration of the EndA variants in the crude reaction mixture determined by western blot analysis.
The activity of wild-type EndA is set to 100%.
630 Nucleic Acids Research, 2011,Vol. 39,No. 2enzyme, did not show any nucleolytic activity in this assay
(data not shown).
DISCUSSION
Streptococcus pneumoniae (pneumococci) are pathogenic
Gram-positive bacteria causing serious infections of the
respiratory system of mammalians and lethal meningitis
(30). Other typical streptococcal diseases like streptococcal
toxic shock syndrome (STSS), necrotizing fasciitis (NF)
and tonsillitis are also triggered by group A streptococci
(GAS; Streptococcus pyogenes) (31). This group of
bacteria exhibit several serotypes expressing different
extracellular virulence proteins, among them nucleases
such as streptodornase (32). Several of these virulence
factors are phage encoded, supporting recombination
and spreading of newly arranged pathogenic genes pre-
sumably creating the high diversity of GAS strains (33).
GAS strains express several types of streptodornases
which support circumvention of the innate immune
response of mammalians resulting in invasive infections
(34,35). One mechanism for this was discovered recently
as streptodornases are able to degrade the DNA scaffold
of NETs (3). NETs are released by activated neutrophils
and consist of expelled chromatin, elastase and other anti-
microbial proteins and kill captured bacteria (5). This
mechanism was also detected for S. pneumoniae
(TIGR4) which express the competence associated
nuclease EndA. This surface-bound nuclease plays a
major role in the degradation of extracellular DNA
to allow pneumococci to escape NETs and regain
viability (4).
In the study presented here, we were unable to express
active forms of EndA in E. coli even when using tightly
regulated intracellular expression systems, anti-sense
strategies or fusion of EndA to the pelB-leader sequence
to secrete the recombinant wild-type enzyme into the
periplasmic space. Due to the intrinsic toxicity of nucle-
ases, cloning and recombinant expression of their genes in
E. coli or other host organisms can be highly problematic
unless, e.g. nuclease inhibitors are available for intracellu-
lar co-expression or the enzyme is produced as an inactive
pro-enzyme that becomes activated by secretion into the
extracellular space (20,36–38). EndA from S. pneumoniae
is a secreted surface exposed endonuclease for which up to
date no inhibitory protein is known (2). All cloning
attempts for the EndA-gene in E. coli led to mutations
in the region coding for the active site and/or insertion
of stop codons in the open reading frame preventing ex-
pression of active full-length protein. EndA could only be
cloned and expressed as an inactive variant in which the
putative active-site histidine residue His160 was
exchanged for alanine (H160A). This variant could be
produced in high amounts either intracellularly as a
His-GST double-tagged protein (Figure 1B) or upon se-
cretion into the extracellular space of E. coli, which
allowed recovery of the nuclease from the culture
medium (Figure 1A). The DNA encoding the H160A
variant was also used to correct for mutations that had
accumulated in templates from previous cloning attempts
in order to revert the coding sequence to the wild-type
sequence according to gene bank entry (gi: 47374; data
not shown).
In order to perform a ﬁrst mutational and biochemical
analyses of EndA, we used overlap extension PCR to
splice DNA templates coding for wild-type EndA and
other desired variants (Figure 4A). Using this approach
we were able to produce a series of EndA variants using a
cell-free expression system. A subsequent analyses of
in vitro translated wild-type EndA and EndA variants con-
ﬁrmed our expectations concerning amino acid residues
constituting the active site of this DRGH-motif containing
nuclease. According to our data and in agreement with the
results obtained for so-called sugar-nonspeciﬁc nucleases
such as Serratia nuclease, Anabaena nuclease or
EndonucleaseG, His160 from the DRGH-motif of
Figure 6. Substrate preference of wild-type EndA: Nucleolytic activity
of wild-type EndA was tested on (A) X174 DNA (single-stranded,
circular), (B) RF I DNA (double-stranded, circular) and (C)R FI I
DNA (double-stranded, nicked). Wild-type EndA shows no substrate
preference (ss—single stranded, sc—super coiled, oc—open circle, li—
linear).
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general base (Figure 7) (25,26,39). This assignment of the
role of His160 as a general base in the catalytic mechanism
of EndA is strongly supported by chemical rescue of the
activity of the H160A variant with excess imidazole in the
reaction buffer (Figure 3). At a slightly basic pH the imid-
azole is deprotonated and able to accept a proton from a
water molecule nearby, thus very likely generating a
nucleophile able to attack a phosphodiester bond. In the
H160A variant, imidazole apparently occupies the space
that is normally ﬁlled by the side chain of the active site
histidine residue in the wild-type enzyme but absent in this
variant. EndA H160A, therefore, is able to catalyze the
cleavage of phosphodiester bonds in the presence of imid-
azole at a slightly basic pH. However, the activity
observed for the rescued EndA H160A variant is approxi-
mately two orders of magnitude lower than that observed
for the in vitro translated wild-type enzyme. In order to
exploit the possibility of restoring activity by chemical
rescue of inactive and thus non-toxic enzyme variants of
EndA that can be produced in E. coli, we are currently
generating other mutants with substitutions of the
active-site histidine residue with the goal to produce
variants with higher activity that can be used, e.g. in
future high-throughput screening assays.
As expected, replacement of amino acid residues from
the conserved DRGH-motif of EndA at the ﬁrst and
second position by alanine (variants D157A and R158A)
also diminishes nuclease activity, albeit to a lower extent
(Figure 4). It is known from the abovementioned studies
concerning Serratia nuclease, Anabaena nuclease and
EndoG, that these residues are involved in proper
positioning of the conserved asparagine residue, which is
binding the divalent metal ion cofactor in the enzyme’s
active site (Figure 7) (7,24). Furthermore, a so-called
H-N-H-motif is characteristic for a large number of
proteins covering a broad variety of functions such as
growth inhibition of bacteria (bacteriocins), phage
defense (restriction endonucleases) and recombination
(homing endonucleases) (27). Sequence analyses show a
conserved H-N-N-motif in EndA (Figure 4C). As two
asparagines (N179, N182) were likely candidates for the
second position within the H-N-N motif, we selected both
of them for an alanine replacement. However, only variant
N182A shows a marked drop in activity indicating that
N182 very likely is part of the active site (Figure 5B) and
probably involved in constraining the loop structure of the
bba-Me ﬁnger as shown for ColE7 at the corresponding
position, thus contributing to the stability of the protein
(28). This explains our ﬁnding that although variant
N182A is less active than wild-type EndA, its concen-
tration obtained in the cell free expression system is
lower due to its general instability compared to variants
with mutations directly affecting catalysis (Figure 5B).
The amount of produced protein for all other variants in
general is correlated with a decrease in activity. The less
active a variant, the more protein can be produced in the
cell-free expression assay, very likely due to degradation of
the template DNA and/or mRNA by more active nuclease
variants. The conserved aspargine residue, which corres-
ponds to the last histidine residue in the H-N-H-motif
is known to be the direct ligand responsible for metal
ion binding as in the case of Serratia nuclease, Anabaena
nuclease, and mitochondrial EndoG (7,25,29).
Replacement of Asp191 by alanine in EndA leads to a
decrease in activity suggesting that this residue is
involved in catalysis, presumably by binding the divalent
metal ion cofactor (Figures 5B and 7).
In the course of genetic transformation, Streptococci
take up single-stranded linear DNA segments (40,41).
Using different phage DNA substrates we could not
detect a truly pronounced substrate preference for the
isolated recombinant enzyme, although single-stranded
virion DNA was cleaved slightly faster than double
stranded DNA (Figure 6). EndA exerts a strong nicking
activity towards supercoiled DNA arguing for a distribu-
tive haplotomic mechanism of action of the enzyme. This
DNA cleavage mechanism is characteristic of monomeric
as well as some dimeric nonspeciﬁc nucleases with inde-
pendently acting subunits and supported by the fact that
EndA behaves as a monomer in size-exclusion chromatog-
raphy (Figure 1C). As single-stranded DNA serves as a
substrate for EndA, the question of regulation of the
enzyme activity on the membrane surface of streptococci
arises. For the 17-kDa entry nuclease (NucA) from
Bacillus subtilis, an inhibition of nuclease activity was
observed in vitro by an 18-kDa protein (Nin) (42).
Several Com proteins on the membrane of B. subtilis are
involved in binding and transport of DNA into the cell
similar as suggested for S. pneumoniae (43). It is, therefore,
tempting to speculate that one of the Com proteins is
interacting with EndA, thereby regulating its function
Figure 7. Catalytic mechanism of wild-type EndA: the proposed
catalytic mechanism of EndA is based on the established catalytic
mechanism of the Serratia nuclease (26). His160 acts as the general
base for the activation of a water molecule. The magnesium ion is
coordinated by Asn191, which is held in place by Asp157, and the
proS-oxygen as well as the 30-oxygen of the phosphate diester. A
glutamic acid residue residue nearby (Glu196 or Glu205 in EndA) is
assumed to be indirectly involved in water-mediated magnesium ion
binding.
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activity within the cell.
Employing inactivating mutations (H160A) or a
cell-free expression system, we were able to produce re-
combinant forms of the streptococcal virulence factor
EndA. We could demonstrate by an alignment-guided mu-
tational analysis that EndA, which contains a DRGH-
and an H-N-H(N)-motif, very likely follows a similar cata-
lytic mechanism as described for other members of the
bba-Me ﬁnger nuclease superfamily, utilizing a divalent
metal ion directly bound by Asn191 and a catalytically
active histidine residue (His160) probably acting as the
general base. Up to date, no mechanism for the regulation
of this nuclease is known that, due to its involvement in
bacterial pathogenesis, has become an interesting target
for future drug design. Being able to produce and/or re-
generate active forms of recombinant EndA and under-
standing its catalytic mechanism is a prerequisite for the
future development of protein or low-molecular-weight
inhibitors for this nuclease, responsible for the degrad-
ation of NETs and circumvention of the innate immune
system during streptococcal infection.
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